icd10free.comPowered by Curo

ICD-10 Coding for Prostatic Adenocarcinoma(C61, D07.5, C79.51)

Save

Learn about the ICD-10 coding for prostatic adenocarcinoma, including documentation requirements, common pitfalls, and billing considerations.

Also known as:
Prostate CancerAdenocarcinoma of the Prostate
Related ICD-10 Code Ranges

Complete code families applicable to Prostatic Adenocarcinoma

C00-D49Primary Range

Neoplasms

→
Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescription
C61Malignant neoplasm of prostate
D07.5Carcinoma in situ of prostate
Primary ICD-10-CM Codes
Malignant neoplasm of prostate
C61Billable
Carcinoma in situ of prostate
D07.5Billable
Differential Codes

Alternative codes to consider when ruling out similar conditions

Benign prostatic hyperplasiaN40.0
Malignant neoplasm of prostateC61

Documentation & Coding Risks

Avoid these common issues when documenting Prostatic Adenocarcinoma.

Omitting Gleason score in documentation

Impact

Clinical: Inadequate treatment planning., Regulatory: Non-compliance with clinical guidelines., Financial: Potential claim denials.

Mitigation

Standardize pathology report templates, Educate clinicians on documentation requirements

Confusing PIN grades in documentation

Impact

Reimbursement: Incorrect coding can lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data reporting.

Mitigation

Clearly specify PIN grade in biopsy reports.

Histological confirmation

Impact

Lack of histological confirmation can lead to audit issues.

Mitigation

Ensure all diagnoses are supported by biopsy reports.

Frequently Asked Questions

Related condition guides

Documentation requirements, coding pitfalls and FAQs for conditions coded with C61.